Preclinical Research on GHK-Cu and Cellular Regeneration Preclinical research on GHK-Cu explores fibroblasts, collagen, glycosaminoglycans, angiogenesis, inflammation, matrix metalloproteinases, tissue inhibitors, and wound models [4], [5], [10], [12]
GHK acts like a delivery truck, carrying copper to the exact cells that use it, then signaling those cells to start rebuilding
How much B12 is administered per injection
Int J Drug Dev & Res 8:021-027 Alzheimers disease (AD) patients are presently without adequate treatment thus new therapeutic approaches are needed to slow and hopefully reverse disease progression
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
At 2mg daily, that's about 60mg